Podchaser Logo
Home
Navigating NSCLC: Merging molecular insights and targeted therapy | Biomarker-guided therapy in NSCLC and beyond | S4E2

Navigating NSCLC: Merging molecular insights and targeted therapy | Biomarker-guided therapy in NSCLC and beyond | S4E2

Released Tuesday, 25th June 2024
Good episode? Give it some love!
Navigating NSCLC: Merging molecular insights and targeted therapy | Biomarker-guided therapy in NSCLC and beyond | S4E2

Navigating NSCLC: Merging molecular insights and targeted therapy | Biomarker-guided therapy in NSCLC and beyond | S4E2

Navigating NSCLC: Merging molecular insights and targeted therapy | Biomarker-guided therapy in NSCLC and beyond | S4E2

Navigating NSCLC: Merging molecular insights and targeted therapy | Biomarker-guided therapy in NSCLC and beyond | S4E2

Tuesday, 25th June 2024
Good episode? Give it some love!
Rate Episode

Dr. Lizza Hendriks explores a complex case involving a 40-year-old male with ALK-rearranged non-small cell lung cancer (NSCLC).

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features